Home › Parkinson's Disease › North Carolina › Winston-Salem
Parkinson's Disease clinical trials in Winston-Salem, NC
4 studies for Parkinson's Disease are looking for participants at sites in and around Winston-Salem (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
RecruitingObservational study
- Wake Forest University School of Medicine, Winston-Salem
Deep Brain Stimulation (DBS) Retrospective Outcomes Study
RecruitingObservational study
- Wake Forest University School of Medicine, Winston-Salem
Use of CereGate Therapy for Freezing of Gait in PD
Recruiting
- Wake Forest University, Winston-Salem
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
RecruitingPhase 4
- Atrium Health Wake Forest Baptist Adult Neurology - Janeway Tower, Winston-Salem
About Parkinson's Disease
Parkinson's disease (PD) is a movement disorder. It causes tremors, stiffness, and slow movement. It gets worse over time. Learn what can help.
More about Parkinson's Disease on MedlinePlus
Parkinson's Disease trials in other cities
- New York City, NY23 studies
- Boston, MA19 studies
- Cleveland, OH18 studies
- Minneapolis, MN17 studies
- Nashville, TN15 studies
- Philadelphia, PA14 studies
- San Francisco, CA14 studies
- New Haven, CT14 studies
- Charleston, SC13 studies
- Farmington Hills, MI13 studies
- Chicago, IL13 studies
- Miami, FL13 studies
Other studies in Winston-Salem
- Cancer (all types)19 studies
- Acute Myeloid Leukemia18 studies
- Multiple Myeloma14 studies
- Breast Cancer14 studies
- Cardiovascular Disease14 studies
- Non-Small Cell Lung Cancer12 studies
- COPD10 studies
- Ovarian Cancer10 studies
- Type 2 Diabetes9 studies
- Myelodysplastic Syndromes9 studies
- Glioblastoma8 studies
- Chronic Lymphocytic Leukemia8 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.